Northern Trust Corp Alector, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Alector, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 719,583 shares of ALEC stock, worth $2.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

719,583

Previous 648,728 10.92%

Holding current value

$2.93 Million

Previous $2.95 Million 14.09%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.34 - $6.58 $307,510 - $466,225	70,855 Added 10.92%	719,583 $3.36 Million
Q2 2024 Aug 14, 2024	SELL	$4.19 - $6.23 $90,064 - $133,913	-21,495 Reduced 3.21%	648,728 $2.95 Million
Q1 2024 May 14, 2024	BUY	$5.69 - $8.08 $316,745 - $449,789	55,667 Added 9.06%	670,223 $4.03 Million
Q4 2023 Feb 13, 2024	SELL	$3.77 - $8.39 $81,088 - $180,460	-21,509 Reduced 3.38%	614,556 $4.9 Million
Q3 2023 Nov 13, 2023	BUY	$5.2 - $8.77 $105,029 - $177,136	20,198 Added 3.28%	636,065 $4.12 Million
Q2 2023 Aug 11, 2023	BUY	$5.86 - $7.93 $108,562 - $146,911	18,526 Added 3.1%	615,867 $3.7 Million
Q1 2023 May 15, 2023	BUY	$5.85 - $9.84 $56,709 - $95,388	9,694 Added 1.65%	597,341 $3.7 Million
Q4 2022 Feb 13, 2023	SELL	$6.88 - $9.55 $42,380 - $58,828	-6,160 Reduced 1.04%	587,647 $5.42 Million
Q3 2022 Nov 14, 2022	SELL	$8.19 - $13.2 $17,903 - $28,855	-2,186 Reduced 0.37%	593,807 $5.62 Million
Q2 2022 Aug 12, 2022	BUY	$7.65 - $14.24 $88,120 - $164,030	11,519 Added 1.97%	595,993 $6.06 Million
Q1 2022 May 13, 2022	SELL	$13.02 - $20.78 $228,006 - $363,899	-17,512 Reduced 2.91%	584,474 $8.33 Million
Q4 2021 Feb 08, 2022	SELL	$19.35 - $25.54 $89,222 - $117,764	-4,611 Reduced 0.76%	601,986 $12.4 Million
Q3 2021 Nov 15, 2021	SELL	$21.65 - $39.49 $221,934 - $404,811	-10,251 Reduced 1.66%	606,597 $13.8 Million
Q2 2021 Aug 13, 2021	BUY	$15.5 - $22.48 $1.04 Million - $1.52 Million	67,404 Added 12.27%	616,848 $12.8 Million
Q1 2021 May 12, 2021	SELL	$14.84 - $22.23 $416,811 - $624,374	-28,087 Reduced 4.86%	549,444 $11.1 Million
Q4 2020 Feb 11, 2021	SELL	$9.4 - $16.7 $175,648 - $312,056	-18,686 Reduced 3.13%	577,531 $8.74 Million
Q3 2020 Nov 16, 2020	SELL	$10.54 - $24.96 $38,850 - $92,002	-3,686 Reduced 0.61%	596,217 $6.28 Million
Q2 2020 Aug 14, 2020	BUY	$21.87 - $33.11 $3.24 Million - $4.9 Million	148,103 Added 32.78%	599,903 $14.7 Million
Q1 2020 May 14, 2020	BUY	$16.25 - $35.28 $1.01 Million - $2.19 Million	61,975 Added 15.9%	451,800 $10.9 Million
Q4 2019 Feb 14, 2020	BUY	$14.17 - $20.3 $223,602 - $320,334	15,780 Added 4.22%	389,825 $6.72 Million
Q3 2019 Nov 13, 2019	BUY	$14.42 - $22.2 $3.95 Million - $6.09 Million	274,268 Added 274.88%	374,045 $5.39 Million
Q2 2019 Aug 13, 2019	SELL	$16.26 - $26.42 $6,178 - $10,039	-380 Reduced 0.38%	99,777 $1.9 Million
Q1 2019 May 13, 2019	BUY	$15.97 - $22.5 $1.6 Million - $2.25 Million	100,157 New	100,157 $1.87 Million

Others Institutions Holding ALEC

# of Institutions

167

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $336M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Alector, Inc. Transaction History